role of 4-drug regimens in treatment of multiple myeloma
Published 4 years ago • 32 plays • Length 5:53Download video MP4
Download video MP3
Similar videos
-
1:02
should frontline myeloma treatment include a 3- or 4-drug regimen?
-
7:15
entering a 4-drug regimen for multiple myeloma treatment
-
3:40
are four-drug combinations more effective than three-drug combinations?
-
4:29
progress in the treatment of r/r multiple myeloma
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
8:37
multiple myeloma
-
41:11
multiple myeloma: what new patients need to know | the patient story
-
5:46
selecting a treatment regimen in r/r multiple myeloma
-
4:30
triplet regimens for relapsed multiple myeloma
-
1:00
new treatment regimens used to provide maximum benefit in multiple myeloma
-
1:48
the impact of cd38-targeted therapy in multiple myeloma
-
1:39
optimal treatment regimens for multiple myeloma
-
3:06
the role of artificial intelligence for precision medicine in multiple myeloma
-
1:02
the role of selinexor in the treatment of multiple myeloma
-
5:34
impressions of an elderly male with r/r multiple myeloma
-
1:47
role of bcma-targeting adcs in the management of myeloma
-
1:38
using bcma-targeting agents in earlier lines of treatment for multiple myeloma
-
1:35
comparing results for 3-drug and 2-drug regimens in relapsed/refractory myeloma
-
1:51
the important role of nurses in the management of patients with multiple myeloma
-
0:35
quadruplet versus triplet regimens in multiple myeloma
-
2:24
the importance of molecular testing in multiple myeloma and how this may impact future treatment
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma